NCT00019214View on ClinicalTrials.gov

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 1997

Study Completion Date

July 31, 2006

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL

MART-1 antigen

BIOLOGICAL

aldesleukin

BIOLOGICAL

gp100 antigen

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH